Showing results (1-10 of 129) with videos related to
Sort By:
Pageof 13
Sleep Medicine Clinics|May 14, 2021
The Long-Term Psychiatric and Cardiovascular Morbidity and Mortality of Restless Legs Syndrome and Periodic Limb Movements of SleepBenjamin Wipper, John W WinkelmanSleep|September 12, 2020
Baseline and 1-year longitudinal data from the National Restless Legs Syndrome Opioid RegistryJohn W Winkelman, Julia Purks, Benjamin WipperNature and Science of Sleep|October 27, 2023
Prevalence of Current Restless Legs Syndrome Symptoms Among Patients Treated with Buprenorphine/Naloxone for Opioid Use DisorderBenjamin Wipper, Michelle Pearl Cooke, John W WinkelmanSleep Medicine|February 8, 2022
Restless legs syndrome severity in the National RLS Opioid Registry during the COVID-19 pandemicBenjamin Wipper, Christopher Romero-Gutierrez, John W WinkelmanNature and Science of Sleep|December 28, 2023
Lack of Efficacy of Suvorexant in People with Insomnia and Poorly Controlled Type 2 DiabetesJohn W Winkelman, Benjamin Wipper, Jordana Zackon, et al.Sleep|April 1, 2020
Topiramate reduces nocturnal eating in sleep-related eating disorderJohn W Winkelman, Benjamin Wipper, Julia Purks, et al.Sleep|January 16, 2026
Effectiveness and dose stability of opioids in patients with restless leg syndrome: 5-year findings from the National RLS Opioid RegistryJohn W Winkelman, Adysn Kilty, Benjamin Wipper, et al.Sleep|August 21, 2021
High national rates of high-dose dopamine agonist prescribing for restless legs syndromeJohn W WinkelmanThe Journal of Clinical Psychiatry|January 2, 2007
Efficacy and tolerability of open-label topiramate in the treatment of sleep-related eating disorder: a retrospective case seriesJohn W WinkelmanPageof 13